TrialJectory is a health technology company that uses artificial intelligence and machine learning to match cancer patients with clinical trials. The company was founded in 2018 and is headquartered in New York City. TrialJectory's platform provides personalized recommendations for clinical trials based on a patient's medical history, genetic profile, and other factors. The company's mission is to improve access to clinical trials and help patients find the best treatment options. TrialJectory has partnerships with leading cancer centers and research institutions, including Memorial Sloan Kettering Cancer Center and the National Cancer Institute.